← Leaderboards
Eliot Gardner
National Institute On Drug Abuse
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
—
By mechanism
—
Top collaborators
No co-investigators on record.
Most similar at National Institute On Drug Abuse
Same institution · by research overlap
Others in their field
Top investigators on “Cues”
- Jose A Luchsinger · Columbia University Health Sciences$34,510,578
- Elaine Fuchs · University Of Chicago$24,226,767
- Eric A Stach · Purdue University$23,050,000
- Rajita Sinha · Yale University$22,430,223
- Barbara J Mason · Scripps Research Institute, The$21,474,646
- Nicholas David Cosford · Sanford Burnham Prebys Medical Discovery Institute$21,157,888
Research focus
CuesBrainCravingRelapseAddictionPharmaceutical PreparationsIn VivoReverse TranscriptionStressPolymerase Chain ReactionPre-ClinicalIntravenousBiochemicalElectrical Stimulation Of The BrainPsychological ReinforcementMicrodialysisRewardsProteinsBehaviorSamplingExposure ToSelf AdministrationAnimal ModelHigh Pressure Liquid Chromatography
Grant awards (70)
Basic brain mechanisms underlying drug addiction, craving, and relapse$1,842,089
ZIA · FY2023 · DA · contact PI
Basic brain mechanisms underlying drug addiction, craving, and relapse$1,670,265
ZIA · FY2022 · DA · contact PI
Basic brain mechanisms underlying drug addiction, craving, and relapse$1,373,973
ZIA · FY2021 · DA · contact PI
Endocannabinoid brain mechanisms and addiction$720,193
ZIA · FY2020 · DA · contact PI
Dopamine D3 receptor antagonists for treating drug addiction: Preclinical models$432,116
ZIA · FY2020 · DA · contact PI
Basic brain mechanisms underlying drug addiction, craving, and relapse$288,077
ZIA · FY2020 · DA · contact PI
Endocannabinoid brain mechanisms and addiction$685,065
ZIA · FY2019 · DA · contact PI
Dopamine D3 receptor antagonists for treating drug addiction: Preclinical models$274,026
ZIA · FY2019 · DA · contact PI
Slow-onset long-acting dopamine transport inhibitors for treating drug addiction$274,026
ZIA · FY2019 · DA · contact PI
Basic brain mechanisms underlying drug addiction, craving, and relapse$137,013
ZIA · FY2019 · DA · contact PI
Endocannabinoid brain mechanisms and addiction$556,092
ZIA · FY2018 · DA · contact PI
Slow-onset long-acting dopamine transport inhibitors for treating drug addiction$278,046
ZIA · FY2018 · DA · contact PI
Basic brain mechanisms underlying drug addiction, craving, and relapse$278,046
ZIA · FY2018 · DA · contact PI
Dopamine D3 receptor antagonists for treating drug addiction: Preclinical models$278,046
ZIA · FY2018 · DA · contact PI
Endocannabinoid brain mechanisms and addiction$418,923
ZIA · FY2017 · DA · contact PI
Glutamatergic compounds for treating drug addiction: Preclinical models$349,102
ZIA · FY2017 · DA · contact PI
Dopamine D3 receptor antagonists for treating drug addiction: Preclinical models$279,282
ZIA · FY2017 · DA · contact PI
Basic brain mechanisms underlying drug addiction, craving, and relapse$209,461
ZIA · FY2017 · DA · contact PI
Slow-onset long-acting dopamine transport inhibitors for treating drug addiction$69,820
ZIA · FY2017 · DA · contact PI
GABAergic compounds for treating drug addiction: Preclinical models$69,820
ZIA · FY2017 · DA · contact PI
Endocannabinoid brain mechanisms and addiction$610,638
ZIA · FY2016 · DA · contact PI
Glutamatergic compounds for treating drug addiction: Preclinical models$508,865
ZIA · FY2016 · DA · contact PI
Dopamine D3 receptor antagonists for treating drug addiction: Preclinical models$407,092
ZIA · FY2016 · DA · contact PI
Basic brain mechanisms underlying drug addiction, craving, and relapse$305,319
ZIA · FY2016 · DA · contact PI
Slow-onset long-acting dopamine transport inhibitors for treating drug addiction$101,773
ZIA · FY2016 · DA · contact PI
GABAergic compounds for treating drug addiction: Preclinical models$101,773
ZIA · FY2016 · DA · contact PI
Endocannabinoid brain mechanisms and addiction$581,370
ZIA · FY2015 · DA · contact PI
Glutamatergic compounds for treating drug addiction: Preclinical models$484,475
ZIA · FY2015 · DA · contact PI
Dopamine D3 receptor antagonists for treating drug addiction: Preclinical models$387,580
ZIA · FY2015 · DA · contact PI
Basic brain mechanisms underlying drug addiction, craving, and relapse$290,685
ZIA · FY2015 · DA · contact PI
GABAergic compounds for treating drug addiction: Preclinical models$96,895
ZIA · FY2015 · DA · contact PI
Slow-onset long-acting dopamine transport inhibitors for treating drug addiction$96,895
ZIA · FY2015 · DA · contact PI
Endocannabinoid brain mechanisms and addiction$415,329
ZIA · FY2014 · DA · contact PI
Glutamatergic compounds for treating drug addiction: Preclinical models$346,107
ZIA · FY2014 · DA · contact PI
Dopamine D3 receptor antagonists for treating drug addiction: Preclinical models$276,886
ZIA · FY2014 · DA · contact PI
Basic brain mechanisms underlying drug addiction, craving, and relapse$207,664
ZIA · FY2014 · DA · contact PI
Slow-onset long-acting dopamine transport inhibitors for treating drug addiction$69,221
ZIA · FY2014 · DA · contact PI
GABAergic compounds for treating drug addiction: Preclinical models$69,221
ZIA · FY2014 · DA · contact PI
Endocannabinoid brain mechanisms and addiction$425,594
ZIA · FY2013 · DA · contact PI
Glutamatergic compounds for treating drug addiction: Preclinical models$354,662
ZIA · FY2013 · DA · contact PI
Dopamine D3 receptor antagonists for treating drug addiction: Preclinical models$283,729
ZIA · FY2013 · DA · contact PI
Basic brain mechanisms underlying drug addiction, craving, and relapse$212,797
ZIA · FY2013 · DA · contact PI
Slow-onset long-acting dopamine transport inhibitors for treating drug addiction$70,932
ZIA · FY2013 · DA · contact PI
GABAergic compounds for treating drug addiction: Preclinical models$70,932
ZIA · FY2013 · DA · contact PI
Endocannabinoid brain mechanisms and addiction$417,256
ZIA · FY2012 · DA · contact PI
Glutamatergic compounds for treating drug addiction: Preclinical models$347,714
ZIA · FY2012 · DA · contact PI
Dopamine D3 receptor antagonists for treating drug addiction: Preclinical models$278,171
ZIA · FY2012 · DA · contact PI
Basic brain mechanisms underlying drug addiction, craving, and relapse$208,628
ZIA · FY2012 · DA · contact PI
Slow-onset long-acting dopamine transport inhibitors for treating drug addiction$69,543
ZIA · FY2012 · DA · contact PI
GABAergic compounds for treating drug addiction: Preclinical models$69,543
ZIA · FY2012 · DA · contact PI
Endocannabinoid brain mechanisms and addiction$520,196
ZIA · FY2011 · DA · contact PI
Glutamatergic compounds for treating drug addiction: Preclinical models$346,798
ZIA · FY2011 · DA · contact PI
Dopamine D3 receptor antagonists for treating drug addiction: Preclinical models$277,438
ZIA · FY2011 · DA · contact PI
Basic brain mechanisms underlying drug addiction, craving, and relapse$208,079
ZIA · FY2011 · DA · contact PI
Slow-onset long-acting dopamine transport inhibitors for treating drug addiction$208,079
ZIA · FY2011 · DA · contact PI
GABAergic compounds for treating drug addiction: Preclinical models$173,399
ZIA · FY2011 · DA · contact PI
Endocannabinoid brain mechanisms and addiction$366,938
ZIA · FY2010 · DA · contact PI
Basic brain mechanisms underlying drug addiction, craving, and relapse$293,550
ZIA · FY2010 · DA · contact PI
Slow-onset long-acting dopamine transport inhibitors for treating drug addiction$293,550
ZIA · FY2010 · DA · contact PI
Dopamine D3 receptor antagonists for treating drug addiction: Preclinical models$293,550
ZIA · FY2010 · DA · contact PI
Glutamatergic compounds for treating drug addiction: Preclinical models$293,550
ZIA · FY2010 · DA · contact PI
GABAergic compounds for treating drug addiction: Preclinical models$293,550
ZIA · FY2010 · DA · contact PI
Basic brain mechanisms underlying drug addiction, craving, and relapse$377,271
ZIA · FY2009 · DA · contact PI
GABAergic compounds for treating drug addiction: Preclinical models$301,817
ZIA · FY2009 · DA · contact PI
Endocannabinoid brain mechanisms and addiction$301,817
ZIA · FY2009 · DA · contact PI
Slow-onset long-acting dopamine transport inhibitors for treating drug addiction$301,817
ZIA · FY2009 · DA · contact PI
Glutamatergic compounds for treating drug addiction: Preclinical models$301,817
ZIA · FY2009 · DA · contact PI
Dopamine D3 receptor antagonists for treating drug addiction: Preclinical models$301,817
ZIA · FY2009 · DA · contact PI
Endocannabinoid brain mechanisms and addiction$311,701
Z01 · FY2008 · DA · contact PI
Endocannabinoid brain mechanisms and addiction$370,042
Z01 · FY2007 · DA · contact PI